FDA Drug recall D-238-2013
Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd
- FDA Drug
- Class III
- terminated
- Published 2013-04-10
On 2013-04-10 the FDA classified a Class III recall of Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd by Dr Reddy S Laboratories, citing labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-238-2013 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2013-03-19 |
| Published | 2013-04-10 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.
Reason
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
Identifiers
| ndc | 55111-179-30 |
|---|---|
| ndc | 55111-179-15 |
| ndc | 55111-179-03 |
| ndc | 55111-179-10 |
| ndc | 55111-180-30 |
| ndc | 55111-180-15 |
| ndc | 55111-180-03 |
| ndc | 55111-180-10 |
| code_info | Lot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-238-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.